Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.


TSXV:RP - Post by User

Comment by bluemoons20on Jan 14, 2024 5:59pm
78 Views
Post# 35826209

RE:RE:RE:RE:RE:RE:RE:Enough Is enough

RE:RE:RE:RE:RE:RE:RE:Enough Is enoughHave to agree.  I  got  sucked in at the beginning too.  Always have to watch for the volume of trading.  I  it  only  trades a few  shares per day  , buying  30,000 plus  makes it impossible to get any out and make  money.

Given the  'News Blackout'   it looks like the  big  boys are looking at how  to  get out  and save what they can for themselves.

Just had another  stock go  private  and get  bought  out.  they  paid  20  per cent over  market.  So similarly here  , thet would mean  7  to 8 cents.  Not a good  scene  for  longer term  folks.

They  seem to have  picked the wrong  people to  partner with  for  every  product.

Seems like the  common theme here is  " If it wasn't for bad luck  , we would have no luck at all."

To make it worth  even consider selling at this  point  I  think  I  would want a minimum  of  25.


GLTA


<< Previous
Bullboard Posts
Next >>